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Steroidogenesis Studied in a Human Adrenocortical Cell Line – 
Effects of Single Chemicals and Mixtures 
Abstract 
Steroidogenesis may be a target for endocrine disrupting chemicals; unfortunately 
data  of  such  effects  is  limited.  The  aim  of  this  thesis  was  to  study  effects  on 
steroidogenesis of single chemicals and mixtures in the human adrenocarcinoma cell 
line H295R.  
Screening for effects on steroid secretion was performed by ELISA. Mechanisms 
were elucidated by analysing levels of steroid intermediates, gene expression and 
enzyme  activity.  Results  from  30  tested  chemicals  showed  qualitative  and 
quantitative differences in effect on cortisol and aldosterone secretion; inhibition, 
stimulation and dissimilar effects on basal vs. induced steroid secretion. Mechanistic 
studies on the fungicide prochloraz revealed dose-dependent inhibition of cortisol 
secretion, in contrast to a biphasic effect, with low-dose stimulation and high-dose 
inhibition,  of  aldosterone  secretion.  The  specific  effects  could  be  explained  by 
inhibition of CYP17A1 and CYP21A2, and by down-regulation of steroidogenic 
genes. 
Effects of single chemicals and equimolar mixtures were compared to estimated 
effects from the concentration addition and independent action prediction models. 
The imidazole mixture of prochloraz, ketoconazole and imazalil caused additive 
effects similar to individual imidazole compounds, with inhibition of cortisol and 
biphasic  effects  on  aldosterone  secretion.  A  modification  of  the  concentration 
addition model was required to predict the biphasic effect. The flavonoids daidzein, 
genistein  and  to  a  lesser  extent  apigenin  inhibited  cortisol,  aldosterone  and 
testosterone secretion. The flavonoid mixture inhibited the secretion of all tested 
steroids, including oestradiol, and in general acted in an additive way. The additive 
effects of the mixtures emphasize the need to assess chemicals together as a group. 
We conclude that the H295R cell line is a promising model for both screening of 
effects  on  steroidogenesis  by  single  chemicals  and  mixtures,  and  for  mechanistic 
analysis. The prediction models are valuable tools for assessment of mixture effects 
on steroidogenesis. 
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1  Introduction 
The endocrine system is essential for communication and coordination of 
body function. The organs of the endocrine system are often termed glands 
and  comprise  the  pituitary,  the  thyroid,  the  parathyroids,  the  testes,  the 
ovary, the adrenal gland and the endocrine pancreas (Boron & Boulpaep, 
2003).  These  glands  communicate  through  hormones,  secreted  into  the 
blood  and  recognized  by  specific,  high-affinity  receptors  in  their  target 
tissues.  The  hypothalamus  and  the  pituitary  gland  are  central  in  the 
hierarchical regulation of the endocrine system, controlling the function of 
the reproductive system, growth and development, and homeostasis within 
the body.  
 
The  adrenal  gland  is  recognized  to  be  the  most  frequently  reported 
toxicological target within the endocrine system (Hinson & Raven, 2006; 
Rosol et al., 2001), but unfortunately it is also the most neglected endocrine 
organ in toxicology research (Diamanti-Kandarakis et al., 2009; Harvey & 
Everett,  2003).  Compounds  interfering  with  the  adrenal  gland  or  other 
endocrine organs are termed endocrine disrupting compounds (EDCs) and 
were defined by the International Programme on Chemical Safety (IPCS) as 
exogenous  substances  or  mixtures  that  alter  function(s)  of  the  endocrine 
system and consequently cause adverse health effects in an intact organism, 
or  its  progeny,  or  (sub)populations  (IPCS,  2002).  These  endocrine 
disrupting  effects  are  of  high  importance  to  indentify,  hence,  rapid  and 
appropriate test models to determine the effects of EDCs on the endocrine 
system are needed.  
   10
1.1  The adrenal gland 
The adrenal gland is a small organ of 4-10 g, located at the cranial part of 
each  kidney.  The  gland  is  histologically  and  functionally  divided  into  a 
cortex  and  a  medulla  (Fig.  1),  each  part  synthesising  different  sets  of 
hormones.  The  medulla  is  responsible  for  production  and  secretion  of 
catecholamines.  The  human  adrenal  cortex  is  divided  into  three  distinct 
zones;  zona  glomerulosa,  zona  fasciculata  and  zona  reticularis  (Fig.  1).  Zona 
glomerulosa is the outermost layer of the adrenal gland and is responsible for 
the  production  and  secretion  of  the  mineralocorticoid  aldosterone. Zona 
fasciculata is located in the middle and produces cortisol, which is the main 
glucocorticoid  in  humans.  The  innermost  layer  of  the  cortex  is  zona 
reticularis.  Reticularis  cells  produce  some  levels  of  cortisol,  but  primarily 
secrete DHEA, DHEA-S and androstenedione, which are weak androgens 
often used for testosterone and oestrogen synthesis in extra adrenal tissues 
(Boron & Boulpaep, 2003; Rosol et al., 2001; Harvey, 1996).  
 
 
 
 
 
 
 
 
 
 
Figure 1. Adrenal histology. (Image kindly 
provided  by  Y.  Ridderstråle  and  L. 
Holm.) 
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1.1.1  Regulation and function of the hormones of the adrenal cortex 
The  effects  of  cortisol  within  the  body  are  diverse.  The  main  effect  of 
cortisol is carbohydrate and protein metabolism (Rang, 2007), but cortisol is 
also  important  for  regulation  of  stress  responses  and  immunologic 
mechanisms  (Ruginsk  et  al.,  2009).  Cortisol  constitutes  the  main 
glucocorticoid  in  humans  and  the  secretion  is  under  influence  of  the 
hypothalamic-pituitary-adrenal (HPA) axis and diurnal rhythm (Fig. 2). The 
HPA-axis is stimulated in response to both psychological as well as physical 
stress,  resulting  in  secretion  of  corticotrophin-releasing  hormone  (CRH). 
CRH  activates  pituitary  corticotrophes,  which  leads  to  the  secretion  of 
adrenocorticotrophic  hormone  (ACTH)  from  the  pituitary  gland. 
Activation  of  cortisol  production  is  subsequently  mediated  through 
membrane bound ACTH-receptors. Upon activation, ACTH generates a 
signalling  cascade  within  the  fasciculata  cells,  mediated  by  cAMP  and 
culminate  in  the  transcription  of  specific  genes  required  for  the  cortisol 
pathway (Sewer et al., 2007). Secreted cortisol binds to receptors in the cells 
of  the  target  tissues  and  acts  as  a  ligand-dependent  transcription  factor 
(Ruginsk et al., 2009). Once the stressful situation for the individual is under 
control negative feedback on the HPA-axis returns cortisol back to basal 
levels. If the stress continues, as in situations of chronic stress, cortisol levels 
are sustained at an elevated level (Redei, 2008). 
 
 
 
 
 
 
 
 
Figure 2. The HPA-axis leading to secretion 
of cortisol. Main cortisol activator in grey. 
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Aldosterone plays a fundamental role in electrolyte and water balance, by 
increasing  reabsorption  of  sodium  and  water  and  increasing  excretion  of 
potassium  (Rang,  2007).  Thus,  the  effect  of  aldosterone  increase  blood 
volume  and,  therefore,  increases  blood  pressure.  Impaired  aldosterone 
secretion  may  lead  to  hypovolaemia  and  circulatory  collapse  (Lumbers, 
1999). Aldosterone release is initiated by angiotensin II (Ang II) from the 
renin-angiotensin  system  (RAS),  increased  potassium  levels,  ACTH, 
endothelin, neuropeptides and serotonin. RAS is the principal activator of 
aldosterone secretion in the adult mammals (Lumbers, 1999; Harvey, 1996) 
and is initiated by the release of renin from the juxtaglomerular cells in the 
kidney as a response to e.g. low sodium load or low blood pressure. Renin 
converts angiotensinogen from hepatocytes into angiotensin I (Ang I) (Fig. 
3), which is subsequently converted into Ang II by angiotensin converting 
enzyme (ACE). Ang II binds to the angiotensin II type 1 receptor (AT1R) 
on the glomerulosa cell surface, thereby activating phospholipase C (Bassett 
et al., 2004; Lumbers, 1999; Rainey, 1999), which result in the release of 
intracellular  calcium  storages.  This  calcium  release  activates  enzymes  and 
transcription of genes required for aldosterone secretion (Sewer et al., 2007; 
Lumbers,  1999).  Potassium  also  activates  aldosterone  secretion  through 
increased  intracellular  calcium  levels,  but  by  stimulating  influx  of 
extracellular  calcium  by  depolarizing  the  cell  membrane  (Foster,  2004). 
ACTH  is  not  recognized  as  a  major  stimulator  of  aldosterone  secretion, 
since glomerulosa cells are known to down-regulate aldosterone synthesis if 
the ACTH level is elevated for a longer period of time (Bassett et al., 2004; 
Lumbers,  1999;  Rainey,  1999).  Upon  release,  aldosterone  binds  to  the 
intracellular  mineralocorticoid  receptor  in  the  target  cells.  The  ligand-
receptor  complex  translocates  to  the  nucleus  and  interacts  with  DNA 
regulating elements to redirect gene expression of the cell (Freel & Connell, 
2004).  Since  aldosterone  promotes  sodium  and  water  retention,  the 
biological effects of aldosterone will offset the original stimuli of aldosterone 
secretion. 
 
The  adrenal  androgens,  mainly  dehydroepiandrosterone  (DHEA)  and 
dehydroepiandrosterone  sulfate  (DHEA-S),  but  also  androstenedione,  are 
synthesised  and  secreted  by  the  reticularis  cells.  Among  the  adrenal 
androgens DHEA-S appears to be the main secreted hormone (Belgorosky 
et al., 2008). ACTH has been proposed as one regulator of this synthesis, but 
there  are  probably  other  stimulators  contributing  in  the  steroidogenic 
activation (Belgorosky et al., 2008; Harvey, 1996). The adrenal androgens 
are recognised as weak stimulators of the androgen and oestrogen receptors,   13 
but are also used as steroid substrates for testosterone and oestrogen synthesis 
in extra adrenal tissues.  
 
Figure 3. Activation pathways of aldosterone secretion. Activators of aldosterone secretion in 
grey. (Based on image from Müller (1995).) 
1.1.2  Steroidogenic pathways 
No  steroid  storages  are  present  within  the  cells  of  the  adrenal  cortex, 
therefore  up-regulation  of  gene  expression  and  stimulation  of  enzyme 
activity of the steroidogenic pathway is needed for hormone secretion. The 
structural template of all steroids is cholesterol. Cholesterol is derived from 
two sources: de novo synthesis by acetate in the adrenal cells or by receptor-
mediated uptake from plasma lipoproteins, which are stored as cholesterol 
acetate  in  neutral  lipid  droplets  (Rosol  et  al.,  2001;  Harvey,  1996).  The 
receptor-mediated uptake in humans is mainly in the form of low-density 
lipoproteins (Sewer et al., 2007; Harvey, 1996). 
 
Upon stimulation of steroidogenesis, cholesterol is transported into the inner 
mitochondrial  membrane  by  the  steroidogenic  acute  regulatory  protein 
(StAR) in a rate limiting step (Omura & Morohashi, 1995). Cholesterol is 
converted into pregnenolone by the cholesterol side-chain cleavage enzyme 
(CYP11A1).  Depending  on  zone  specificity  pregnenolone  is  further 
converted  by  a  number  of  steroidogenic  enzymes,  most  of  which  are 
cytochrome P450 (CYP) enzymes (Fig. 4). In zona fasciculata pregnenolone 
is reduced to progesterone by the 3 -hydroxysteroid dehydrogenase type II 
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enzyme  (3 HSD2)  or  hydroxylated  to  17 -OH-pregnenolone  by 
CYP17A1. 17 -OH-pregnenolone is further reduced by 3 HSD2 to 17 -
OH-progesterone,  and  progesterone  can  be  hydroxylated  to  17 -OH-
progesterone  by  CYP17A1  as  well.  Hydroxylation  of  17 -OH-
progesterone  by  CYP21A2  leads  to  the  formation  of  11-deoxycortisol, 
which is subsequently hydroxylated into cortisol by CYP11B1. CYP11A1 
and  CYP11B1  are  located  in  the  mitochondria,  whereas  the  rest  of  the 
steroidogenic  enzymes  required  for  cortisol  synthesis  are  located  in  the 
endoplasmic reticulum.  
 
Figure  4.  Steroidogenic  pathways  in  the  adrenal  gland.  Enzymes  are  indicated  in  bold. 
CYP17A1-activity is indicated as (a) hydroxylase activity and (b) lyase activity. Steroidogenic 
pathways taking place in extra adrenal tissues are written in grey. 
In glomerulosa cells pregnenolone is reduced to progesterone by 3 HSD2, 
followed  by  hydroxylation  by  CYP21A2  into  11-deoxycorticosterone 
(DOC).  The  final  step  in  aldosterone  secretion  is  taking  place  in  the 
mitochondria by an enzyme exclusively expressed in the glomerulosa cells, 
CYP11B2. It has been argued that the hydroxylation step/steps from DOC 
to  aldosterone  is  either  carried  out  solely  by  CYP11B2  (Lisurek  & 
Bernhardt,  2004;  Payne  &  Hales,  2004),  or  by  the  help  of  CYP11B1. 
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CYP11B1 is known to synthesise corticosterone, but cannot hydroxylate 
corticosterone into aldosterone (Hakki & Bernhardt, 2006; Payne & Hales, 
2004). The zonal expression of CYP11B1 in the glomerulosa cells has not 
been fully resolved (Rainey, 1999). 
 
The reticularis cells share the initial part of the steroidogenic pathway with 
the cortisol pathway. In contrast to zona fasciculata, cells of zona reticularis 
require a lyase activity of CYP17A1 to proceed with the conversion of 17 -
OH-pregnenolone  and  17 -OH-progesterone  to  DHEA  and 
androstenedione, respectively. This lyase activity is promoted in the zona 
reticularis  (Rainey  &  Nakamura,  2008)  and  is  enhanced  by  the  electron 
transfer  protein  cytochrome  b5  (CYP5)  (Auchus  et  al.,  1998).  CYP5  is 
expressed in all cells of the cortex, but to a higher extent in the reticularis 
cells  (Rainey  &  Nakamura,  2008).  DHEA  is  either  reduced  into 
androstenedione  by  3 HSD2,  or  catalyzed  to  DHEA-S  through  the 
addition of a sulphate group by SULT2A1. In extra adrenal tissues adrenal 
androgens are converted into testosterone and oestrogens by the action of 
17 HSD and aromatase (CYP19).  
1.2  The H295R cell line 
In 1980 a woman from the Bahamas had her right adrenal gland removed 
due  to  an  adrenocortical  carcinoma  (Gazdar  et  al.,  1990).  Parts  of  the 
tumour  were  used  to  establish  the  cell  line  NCI-H295  (H295). 
Characterization revealed that it secreted all of the hormones of the adrenal 
cortex,  including  the  intermediate  steps  of  the  steroidogenic  pathways 
(Rainey et al., 2004; Gazdar et al., 1990). It was also shown that the cell line 
expressed all the required enzymes for this secretion, regardless of normal in 
vivo zone specificity. In contrast to the normal adrenal gland, H295 cells also 
produced low levels of testosterone and oestrogens (Gazdar et al., 1990). 
The  H295  cell  line  is  available  through  the  American  Type  Culture 
Collection (ATCC).  
 
Three substrains have been derived from the original H295 cell line (Rainey 
et al., 2004), the most frequently used cell line is H295R. The H295 cells 
were  initially  grown  as  floating  aggregates  in  foetal  bovine  serum 
supplemented medium. By switching  to a medium supplemented with  a 
serum substitute called Ultroser G, growth rate of the cells was enhanced 
while still retaining steroidogenic function (Rainey et al., 2004). Selecting 
for cells attached to culture dishes lead to the establishment of the H295R   16
cell line. However, due to problems with importing Ultroser to the USA a 
population of the H295R cells were selected to grow in a serum substitute 
called Nu-Serum type I (Rainey et al., 2004). The H295R cells are available 
through ATCC.  
 
Figure 5. H295R cells cultured in the presence of (A) DMSO, (B) forskolin, 10 µM, (C) H2O 
and (D) Ang II, 100 nM. 20x magnification, stained with haematoxylin and eosin.  
The H295R cell line expresses the required enzymes and transport proteins 
needed for steroid hormone synthesis, as the parental cell line. The H295R 
cell line also retains the capability to produce and secrete sex hormones, 
which  another  substrain,  H295A,  cannot  (Samandari  et  al.,  2007).  In 
comparison to the H295A cell line H295R produce slightly lower amounts 
of  aldosterone  (Samandari  et  al.,  2007).  H295R  cells  respond  to  cAMP 
inducers, Ang II and weakly to ACTH (Samandari et al., 2007; Rainey et 
al., 2004). Treatment  with Ang II  or potassium  makes the H295R cells 
adopt  a  more  “glomerulosa-like”  behaviour  with  increased  secretion  of 
aldosterone. Forskolin treatment leads to a more “fasciculata-like” behaviour 
of  the  cells,  with  increased  synthesis  of  cortisol  and  adrenal  androgens 
(Oskarsson et al., 2006; Rainey et al., 2004). Some structural differences in 
morphology  of  the  cultured  cells  can  be  seen  following  treatment  with 
forskolin and Ang II (Fig. 5). Forskolin is a specific adenylyl cyclase activator 
and  stimulates  steroidogenesis  through  activation  of  cAMP  and  protein   17 
kinase A. Forskolin is used to mimic ACTH stimulation, since the H295R 
cells are only weakly responsive to ACTH (Rainey et al., 2004). 
 
It has been shown that forskolin-stimulated steroidogenic gene expression in 
H295R cells mimics mRNA expression levels of human adrenal cells in vivo 
(Oskarsson et al., 2006). Gene expression levels can successfully be analysed 
in H295R cells by quantitative real-time RT-PCR (Zhang et al., 2005). 
Effects on steroidogenic gene expression levels have been reported following 
treatment with pesticides, natural compounds, pharmaceuticals and different 
food  additives  (Harvey  et  al.,  2007).  Hence,  the  H295R  cell  line  is  a 
promising tool for the assessment of effects of chemicals on steroidogenic 
gene expression, as well as effects on hormone secretion. 
 
The H295R cell line has attracted much attention as a potential screening 
model for toxic effects on sex hormone secretion, since the cell line secretes 
testosterone and oestrogens. The H295R cell line is currently undergoing a 
test  method  validation  program  for  the  Organization  for  Economic 
Cooperation and Development (OECD) as a potential tool for screening 
purposes of the effects on testosterone and oestradiol secretion (Hecker et 
al., 2007). But the H295R cell line is originally derived from the adrenal 
cortex and may hence be a potential tool to address effects on the adrenal 
secretion of cortisol and aldosterone as well.  
1.3  Action of endocrine disruptors on the adrenal cortex 
Endocrine disrupting compounds are found among pharmaceuticals, food 
additives,  environmental  pollutants,  and  pesticides  and  are  known  to 
interfere with the endocrine system through various mechanisms. In general, 
the  primary  concern  of  EDCs  has  been  receptor-mediated  endocrine 
disruption. However, these receptor-mediated effects are often weak and 
there is a growing concern of the more potential effects of EDCs to cause 
specific  effects  on  endocrine  organs  (Sharpe  &  Irvine,  2004).  The  direct 
interaction of EDCs with the endocrine organs may alter hormone synthesis 
or metabolism and hence affect homeostasis. For the adrenal gland, these 
direct  and  organ  specific  effects  of  EDCs  may  affect  any  step  in  the 
steroidogenesis,  e.g.  the  function  of  StAR,  or  impair  activity  of 
steroidogenic enzymes (Harvey & Johnson, 2002). In fact, the adrenal gland 
has been reported as the most common toxicological target of all endocrine 
organs (Rosol et al., 2001) and the need to establish effects of EDCs on 
adrenal steroidogenesis has been pointed out (Harvey et al., 2007).   18
1.3.1  Toxic effects on the adrenal cortex 
The structural arrangement of the adrenal gland positions almost every cell 
of the cortex in direct contact with a blood vessel (Harvey, 1996). Such a 
rich blood supply to the cortex is not only important for the rapid delivery 
of adrenal hormones into the blood, but also increases the risk of exposure 
to EDCs. Further, the high lipid content of the adrenal cortex makes it a 
vulnerable tissue for accumulation of lipophilic toxic compounds circulating 
the blood.  
 
The most common mechanism of primary toxic action in the adrenal gland 
involves interaction with one or more steroidogenic enzymes (Harvey et al., 
2007;  Rosol  et  al.,  2001;  Harvey,  1996).  The  interaction  with  the 
steroidogenic enzymes may cause inhibition of steroidogenesis, or generate 
free oxygen radicals through enzymatic metabolism of chemicals present in 
the cells. Further, interference with gene expression levels for steroidogenic 
genes or receptors, such as the AT1R, have been reported for some EDCs 
(Hinson & Raven, 2006).  
 
As a result of the multiple levels of control of adrenal function there are also 
many potential sites of actions for EDCs in extra adrenal tissues that can 
affect adrenal homeostasis. Any step within the HPA-axis or RAS may be 
susceptible for EDCs, thereby causing secondary changes to the function of 
the adrenal cortex.  
1.3.2  Models for studies of adrenal toxicity 
In adrenal toxicology in vivo studies are often crucial to establish effects on 
complex pathways such as the HPA-axis (Harvey, 1996). Species differences 
may, however, complicate the interpretation of results and extrapolation to 
human risk assessment (Harvey & Everett, 2006). For example, the main 
glucocorticoid in rats is corticosterone and not cortisol, since the rat (and 
mouse) do not express CYP17 in the adrenal gland (Payne & Hales, 2004; 
Harvey, 1996). The lack of CYP17 expression in rat/mouse adrenal also 
results in a difference of androgen secretion pattern compared to the human 
adrenal gland.  
 
The  recommended  strategy  for  endocrine  toxicity  testing  is  an  initial 
screening  of  effects  by  in  vitro  models  and  short-term  in  vivo  studies, 
followed  by  reproduction  studies  in  vivo  (Harvey  &  Everett,  2006).  Cell 
based models are considered promising tools for research and development 
in areas requiring screening of multiple compounds, such as in toxicology,   19 
drug discovery and environmental monitoring (Banerjee and Bhunia, 2009). 
Rainey  et  al.  (2004)  presented  some  of  the  available  cell  lines  of  use  in 
adrenal  in  vitro  studies.  Two  of  them  are  non-human;  the  murine 
adrenocortical cell line Y1, and bovine adrenocortical cell lines based on 
primary cell cultures. The murine Y1 cell model provides a good system to 
study both the molecular and biochemical characteristics of adrenal function, 
but still is a model of non-human origin. Therefore the H295/H295R cell 
line has been proposed as a powerful tool in adrenal toxicity. This model is 
not only human specific, but can also be used for the direct assessment of 
cytotoxicity.  The  OECD  validation  process  of  the  H295R  cells  looks 
promising in the establishment of a  screening tool for specific effects on 
human testosterone and oestradiol secretion. 
 
The most obvious limitation of in vitro models for adrenal toxicity studies is 
the lack of negative feedback and crosstalk with other organs within the 
body. Metabolism of chemicals in extra adrenal tissues may generate potent 
and  activated  forms  of  a  chemical,  which  may  affect  the  adrenal  cells 
differently compared to the original compound (Harvey & Everett, 2006). 
Further, some models are based on cell lines derived from tumors and it can 
be  argued  that  these  cells  may  act  differently  compared  to  primary  cell 
cultures or cells in vivo. Despite the pros and cons of in vitro models, they 
still have advantages compared to in vivo studies in that it may reduce the use 
of  exposed  animals,  reduce  the  costs  for  testing  and  give  mechanistic 
insights. 
1.4  Chemicals affecting adrenal steroidogenesis 
A  wide  variety  of  chemicals  has  been  found  to  cause  histopathological 
and/or functional changes in the adrenal gland (Harvey, 1996). In this thesis 
a number of compounds have been used that cause, or are suspected to 
cause,  effects  on  steroidogenesis.  Among  the  tested  compounds  are 
environmental  contaminants,  naturally  occurring  dietary  compounds, 
pharmaceuticals and pesticides.  
1.4.1  Imidazole compounds 
Imidazoles  belong  to  the  azoles  and  are  recognized  to  inhibit  lanosterol 
14 -demethylase  (CYP51).  This  enzyme  is  required  in  ergosterol 
biosynthesis, which is essential for maintaining the integrity of fungal cell 
membranes  (Mason  et  al.,  1987;  van  den  Bossche  et  al.,  1980;  Siegel  & 
Ragsdale, 1978). Hence, imidazoles are used as antifungal compounds in   20
agriculture  or  medical  treatments.  The  enzyme  inhibition  is  due  to  an 
interaction of the nitrogen at the basic site in the imidazole moiety with the 
iron  atom  of  the  CYP  haem-group  (White  et  al.,  1998).  However,  this 
interaction is not exclusive for CYP51 and imidazoles are known to inhibit 
other CYPs, including those in mammalian steroidogenesis (Ayub & Levell, 
1987).  In  this  thesis,  three  imidazoles  have  been  studied;  ketoconazole, 
prochloraz and imazalil (Fig. 6). 
 
Figure 6. Chemical structure of the imidazoles prochloraz, ketoconazole and imazalil. 
Ketoconazole  is  an  imidazole  originally  used  for  antifungal  treatment. 
Ketoconazole has been shown to inhibit cortisol secretion, both in vitro and 
in  vivo,  and  is  occasionally  used  in  treatment  of  Cushing’s  disease 
(Engelhardt & Weber, 1994; Kong et al., 1992). The impaired secretion of 
cortisol is due to inhibition of steroidogenic enzymes (Johansson et al., 2002; 
Rotstein et al., 1992; Ayub & Levell, 1989; Ayub & Levell, 1987; Nagai et 
al., 1986; Loose et al., 1983), but ketoconazole has been reported to down-
regulate steroidogenic genes as well (Gracia et al., 2006; Zhang et al., 2005; 
Hilscherova et al., 2004).  
 
The  imidazole  prochloraz  has  suspected  adverse  effects  on  reproduction. 
Studies  in  rats  have  shown  that  male  offspring  are  feminized  following 
perinatal  prochloraz  exposure.  This  effect  has  partly  been  explained  by 
reduced foetal production of testosterone and is associated with increased 
levels of progesterone (Blystone et al., 2007a; Blystone et al., 2007b; Laier et 
al., 2006; Vinggaard et al., 2005). Prochloraz has been  shown  to inhibit 
gonadal steroidogenesis, antagonize the androgen and oestrogen receptors 
and agonize the Ah-receptor (Vinggaard et al., 2006). The reduced level of 
testosterone has been proposed to be due to inhibition of the steroidogenic 
enzyme CYP17A1 (Vinggaard et al., 2006). 
 
Imazalil  is  used  as  a  fungicide  in  agriculture  (EFSA,  2010; Ortelli  et  al., 
2005). Imazalil has been shown to inhibit steroidogenic enzymes (Trosken et 
Prochloraz Ketoconazole Imazalil  21 
al.,  2006;  Mason  et  al.,  1987),  which  may  lead  to  impaired  oestrogen 
synthesis (Mason et al., 1987).  
1.4.2  The flavonoids 
Polyphenols are abundant in various sources of plants and we are exposed to 
these via food (Manach et al., 2004; Ross & Kasum, 2002). There are several 
thousand polyphenols identified in higher plants, whereof one group is the 
flavonoid.  This  group  is  in  turn  divided  into  six  subgroups;  flavonol, 
flavone,  isoflavone,  flavanone,  anthocyanidin  and  flavanol.  Compounds 
from two of these groups have been investigated in this thesis, the flavones 
and  the  isoflavones  (Fig.  7).  The  chemicals  of  these  groups  contain  a 
substituted  chromon-4-one  structure.  The  classification  into  different 
flavonoid chemicals depends on type and location of the substituents. The 
only  difference  between  the  isoflavones  daidzein  and  genistein  is  one 
hydroxyl substituent in position 5 of the chrome-4-one backbone. Further, 
the structure of the flavone apigenin has the phenol group in position 2 
instead of position 3 as in the isoflavones. Due to the flavonoid structural 
resemblance  to  17 -oestradiol  (Fig.  7)  they  are  often  called  phyto-
oestrogens.  In  plants,  many  of  the  flavonoids  are  found  as  glycosides 
(Manach et al., 2004). These glycosides are hydrolyzed into active aglycons 
before absorption in the intestine (Patisaul & Jefferson, 2010).  
 
Figure  7.  Chemical  structure  of  the  flavonoid  subgroups  flavone  and  isoflavone,  in 
comparison to the chemical structure of 17 -oestradiol. Different flavonoids are identified by 
type of substitution in positions R1-R3. 
Flavonoids  can  bind  to  the  oestrogen  receptors,  due  to  the  chemical 
resemblance  to  17 -oestradiol.  However,  the  receptor  affinity  for  the 
flavonoids  is  one  to  three  orders  of  magnitude  lower  than  that  of  17 -
oestradiol  (Sotoca  et  al.,  2008).  A  growing  concern  of  EDCs  is  not  the 
receptor-mediated  effects,  but  the  direct  interference  with  the  hormone 
synthesis in endocrine organs (Diamanti-Kandarakis et al., 2009; Sharpe & 
Irvine, 2004). Flavonoids are reported to interfere with steroidogenesis by 
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inhibition and activation of key steroidogenic enzymes (Whitehead & Rice, 
2006), which may alter hormone secretion levels. 
 
The  isoflavones  are  found  in  soybeans  and  soy-based  food  products 
(Mortensen et al., 2009; Manach et al., 2004). The main active isoflavones 
from  soybeans  are  daidzein  and  genistein,  the  aglycons  of  daidzin  and 
genistin  respectively.  Traditional  Asian  diets  can  result  in  an  isoflavone 
intake of 8-50 mg/day, while a typical western diet can range from 1-3 
mg/day (Mortensen et al., 2009). Mean serum concentrations of isoflavones 
(daidzein,  genistein,  and  equol  (a  daidzein  metabolite))  are  higher  in 
Japanese men and women (0.8 µM) consuming a traditional diet than in 
Scottish men (0.05 µM) with a low consumption of soy-based food. Infants 
fed a soy-based diet reach very high serum concentrations (mean of 4 µM) 
of isoflavones (Mortensen et al., 2009; Heald et al., 2006). Isoflavones have 
been  ascribed  beneficial  biological  properties  such  as  anticancer,  anti-
inflammatory,  antioxidant  and  antiviral  effects  (Mortensen  et  al.,  2009; 
Scalbert et al., 2005; Patisaul & Jefferson, 2010). However, there is no firm 
conclusion  whether  flavonoids  are  beneficial,  or  if  they  may  in  fact  be 
harmful  to  human  health  (Patisaul  &  Jefferson,  2010).  Isoflavones  are 
recognized to decrease cortisol secretion in vitro in cell cultures (Ohno et al., 
2002; Mesiano et al., 1999) and glucocorticoids in vivo in rats (Ohno et al., 
2003).  Further,  inhibitory  effects  on  testosterone  secretion  have  been 
demonstrated in vitro (Taxvig et al., 2010) and in vivo (Ohno et al., 2003), in 
contrast  to  increased  levels  of  oestradiol  secretion  in  vitro  (Taxvig  et  al., 
2010). Daidzein and genistein have been shown to be potent inhibitors of 
3 HSD2 and to a lesser extent inhibit CYP21A2 (Ohno et al., 2004; Ohno 
et al., 2002; Mesiano et al., 1999). Further, daidzein and genistein have been 
shown  to  inhibit  17 HSD  (Le  Bail  et  al.,  2000)  and  genistein  has  been 
reported to stimulate activity of CYP19 (Sanderson et al., 2004). 
 
The flavone apigenin is the aglycon of apiin and most often found in food 
such as parsley, celery and citrus (Meyer et al., 2006; Manach et al., 2004). 
Apigenin is, as the isoflavones, recognized with beneficial biological effects 
such  as  anticancer,  anti-inflammatory,  antioxidant  and  anti-proliferative 
properties  (Patel  et  al.,  2007;  Meyer  et  al.,  2006).  Inhibitory  effects  on 
cortisol secretion have been demonstrated for apigenin in vitro (Ohno et al., 
2002)  and  by  decreasing  glucocorticoid  levels  in  rats  (Yi  et  al.,  2008). 
Inhibitory effects of apigenin on steroidogenic enzyme activity have been 
reported for 3 HSD2 (Ohno et al., 2004; Ohno et al., 2002) and CYP19 
(Sanderson et al., 2004).   23 
1.5  Chemical mixtures 
Risk  assessment  of  chemical  exposure  has  generally  been  performed  by 
addressing  effects  of  single  chemicals.  However,  exposure  of  single 
chemicals is not the likely way of exposure to EDCs (Diamanti-Kandarakis 
et al., 2009). By assessing risk from single chemicals separately, the total risk 
of chemical exposure may be underestimated. This is not only due to rare 
combination effects displaying synergism, but simply through additive effects 
of large numbers of chemicals. This fact has brought about an increasing 
interest in mixtures and their toxicological effects in human risk assessment. 
 
Chemical  mixtures  are  defined  as  simple  or  complex  mixtures.  Simple 
mixtures consist of rather few compounds, ten or less (Groten et al., 2001). 
The composition of a simple mixture is often known, both qualitatively as 
well  as  quantitatively.  Pesticides  are  a  good  example  of  simple mixtures, 
where some compounds are combined to make the product more efficient. 
In contrast, the chemical composition of a complex mixture is often not 
fully known, which may not be surprising when a complex mixture can 
contain tens to thousands of chemicals (Groten et al., 2001). The most likely 
type of mixture humans and animals are exposed to is complex mixtures, 
however, testing for all kinds of complex mixtures are virtually impossible. 
Therefore a number of mathematical prediction models have been brought 
forth to facilitate the evaluation of mixture effects. These models are often 
based on some sort of assumption regarding the mode of action (MoA) of a 
specific compound, either by acting by the same or different MoA.  
 
The  definition  of  MoA  in  mixture  toxicology  is  not  distinct.  In 
pharmacology, and toxicology, mechanism of action denotes the molecular 
events  of  a  chemical  leading  to  a  specific  biological  response  in  a  target 
organ. In contrast, MoA gives a more general description of the effect of a 
chemical, referring to the type of response (Borgert et al., 2004). Two of the 
most  frequently  used  prediction  models  are  concentration  addition  (CA) 
(Loewe & Muischnek, 1926), also known as dose addition, and independent 
action (IA) (Bliss, 1939), also known as response addition. CA is based on 
the  assumption  that  the  chemicals  in  the  mixture  act  through  the  same 
MoA,  whereas  IA  assumes  the  chemicals  of  the  mixture  to  act  through 
different MoA. Both models are based on the assumption that a chemical in 
a mixture do not interact with the other chemicals.  
 
By comparing an observed effect with the CA and/or IA predicted effects of 
the mixture it is possible to establish how the chemicals in a mixture act in   24
combination. In mixture research chemicals are often defined to act through 
additive, synergistic or antagonistic effects. In contrast to the mathematical 
use  of  “additivity”  this  term  in  toxicology  is  ascribed  chemicals  that  act 
together to produce an effect without enhancing or diminishing the effect of 
the  other  compound  (Kortenkamp,  2007).  Deviation  from  additivity  is 
regarded  as  an  interaction  between  the  effects  of  the  chemicals  and  is 
defined as synergism if the observed effect is greater than additive, or as 
antagonism  if  the  observed  effect  is  lower  than  expected  (Groten,  2000; 
Berenbaum,  1989).  To  make  these  distinctions  it  is  crucial  to  chose  the 
correct model based on the correct assumptions about MoA, otherwise the 
model  erroneously  may  ascribe  the  compounds  with  synergistic  or 
antagonistic effects (Kortenkamp, 2007). 
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2   Aim of thesis 
The  overall  aim  of  this  thesis  was  to  investigate  the  effects  of  single 
chemicals and mixtures on steroidogenesis in the human adrenocarcinoma 
cell line H295R, by performing screening and mechanistic studies. 
    26
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3  Material and Methods 
The following is a brief description of the material and methods used in this 
thesis. For detailed information the reader is referred to the material and 
methods in each paper. 
3.1  Chemicals, solubility and cell viability 
In  this  thesis,  chemicals  with  known  or  suspected  effects  on  adrenal 
steroidogenesis have been used. Most of these chemicals have been dissolved 
in dimethyl sulfoxide (DMSO), except for cadmium, lithium, arsenite, and 
Ang II, which have been dissolved in H2O. 
 
Despite solubility in DMSO some chemicals had a tendency to precipitate 
after dilution in cell culture medium. Effective concentrations of a chemical 
may depend on this solubility; hence much effort was put into determining 
the  concentration  where  no  precipitation  was  shown.  This  maximum 
concentration was later used as a starting point for cytotoxicity screening of 
each chemical. Precipitation tests were carried out in 96-well plates in cell 
culture medium used for chemical treatment. Precipitation could easily be 
detected  by  microscope  examination  (Fig.  8).  None  of  the  tested 
concentrations of the chemicals in paper I were limited by precipitations. 
 
Cell  viability  assays  were  performed  in  96-well  plates.  Viability  was 
measured with a MTS reduction test, wherein a tetrazolium compound is 
transformed to a coloured formazan product by mitochondrial activity in 
viable  cells.  After  a  one-hour  incubation  absorbance  at  490  nm  was 
measured for each well. The absorbance was proportional to the number of 
living  cells  in  the  culture.  The  concentration  to  use  in  paper  I  was 
determined based on maximum 10% reduction of cell viability (ICmax10). If a 
concentration  was  regarded  as  toxic  according  to  this  definition,  lower   28
concentrations were tested to establish a non-toxic concentration. Thus, the 
concentrations used in this thesis are believed to cause specific effects on 
steroid secretion without inducing cytotoxic effects.  
 
Figure 8. Precipitation of chemicals in serum-free cell culture medium following 24 hours 
incubation. (A) Ketoconazole, 70 µM and (B) 6-hydroxyflavone, 40 µM. 10x magnification. 
Tests  of  cell  viability  were  always  run  concurrently  with  the  chemical 
experiments. 
3.2  Cell treatment 
H295R cells were seeded 72 h before exposure, in order to get the cells 
attached and about 70-80% confluent before treatment with the chemical. If 
different types of cell-culture plates were used (i.e. different number of wells 
in the plate), adjustments were done to maintain the same proportion of 
cells per volume and surface area. This resulted in: 
   6-well plates: 5.0   10
5 cells per well, 2.5 ml medium 
  12-well plates: 2.0   10
5 cells per well, 1.0 ml medium 
  96-well plates: 1.7   10
4 cells per well, 0.1 ml medium 
 
On  the  day  of  exposure  culture  medium  was  removed  and  serum-free 
medium  containing  the  test  chemical  was  added  to  each  well  in  an 
appropriate volume. Treatments were performed for 24 h. 
 
Stimulation of fasciculata and/or glomerulosa like behaviour of the H295R 
cells, with increased cortisol and aldosterone secretion, was achieved by co-
treating the cells with 10 µM forskolin and 100 nM Ang II, respectively.   29 
3.3  Enzyme activity assays 
There are different ways to measure enzyme activity within a system. In this 
thesis an excess of steroid substrates and test chemical have been added to 
the cells and the level of the end product, or intermediate steps of a specific 
steroid pathway, has been measured by ELISA. For the CYP17A1-activity 
assay trilostane was used to block the activity of 3 HSD2, redirecting the 
steroid  substrates  away  from  mineralo-  and  glucocorticoid  synthesis  to 
DHEA production (Fig. 9). Thus, effects on CYP17A1-activity could be 
determined by measuring the level of DHEA in the cell culture medium.  
 
Emphasis has been put into establishing a substrate and 3 HSD2-inhibitor 
concentration that did not saturate the measured pathways.  
 
Figure 9. Effects on progesterone and DHEA secretion following treatment of H295R cells 
with increasing concentrations of trilostane (Tri) in order to block the activity of 3 HSD2. 
Pregnenolone (Preg) was added as a steroid substrate.  Effect of vehicle control (DMSO) is 
indicated with a horizontal line in the figure at 100%. 
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3.4  Mixture predictions 
3.4.1  Concentration addition 
The concept of CA was suggested by Loewe and Muischneck (1926). It is 
applied in cases where the chemicals of a mixture are known, or suspected, 
to  act  through  a  common  MoA.  The  only  difference  between  the 
compounds  is  the  individual  potency,  hence  it  is  believed  that  one 
compound  in  a  mixture  can  be  partly  or  fully  replaced  with  another 
compound of similar potency, without influencing the original effect of the 
mixture. The effect of the mixture is predicted based on the dose-response 
curves of the individual compounds within the mixture. 
 
Fitting  a  curve  to  observed  responses of  the  individual  chemicals  in  the 
mixture can be done by a log-logistic dose-response model: 
  y  
100%
1  xe   
b   (1) 
, where the data is fitted with a common upper limit of 100% and a lower 
limit  set  to  zero.  The  x  represents  concentration,  e  is  the  50%  effect 
concentration (EC50) and b is proportional to the slope of the curve around e 
(Steribig et al., 1993).  
 
The  generated  curve  can  then  be  applied  in  the  model  of  CA  as  it  is 
described by Backhaus et al. (2004b), which states that: 
 
ci
ECxi i 1
n
   1  (2) 
, where ECxi gives the concentration of chemical i needed to provoke the 
effect  x  when  applied  singly  and  ci  denotes  the  concentration  of  that 
chemical in the mixture, when the total mixture concentration provokes the 
effect  x.  Knowing  the  shapes  of  the  dose-response  curves  of  the  single 
chemicals and their relative contribution to the mixture, the expected effect 
of any concentration of the mixture can be calculated. This is done by first 
retrieving  a  range  of  ECx  values  for  all  the  individual  chemicals  in  the 
mixture. Then, for each ECx value, the mixture concentration giving the 
effect x is calculated by substituting ci in equation 1 with piz, where pi is the 
proportion of chemical i (0 < pi < 1) of the mixture concentration called z:    31 
 
piz
ECxi i 1
n
   1  (3) 
Solving the equation for z gives that, 
  z  
1
pi
ECxi i 1
n
 
  
  
     
  
  
     
  (4) 
A drawback with the CA model is that it does not take non-monotonic 
responses  into  consideration.  A  single  endpoint,  for  example  hormone 
secretion, may be either activated or inhibited by different compounds at 
different concentrations, making dose-response relationships of their activity 
non-monotonic.  Recent  research  has  emphasized  that  non-monotonic 
dose-response  relationships  are  occasionally  observed  in  toxicology  with 
low-dose  effects  distinct  from  effects  observed  at  high  dose  (Calabrese, 
2008). To predict these types of mixture effects a modified CA model has 
been proposed (Belz et al., 2008). To describe a non-monotonic curve a 
log-logistic  dose-response  model,  including  a  term  for  the  stimulatory 
response, is used: 
  y  
100%  fx
1  xe   
b   (5) 
The data is fitted with a common upper limit of 100% and a lower limit set 
to zero. In this model the parameter f is proportional to the size of the 
response increase, while e denotes the infliction point of the decreasing part 
of the dose-response curve (Brain & Cousens, 1989).  
 
In the modified CA model it is assumed that the magnitude of stimulation 
follows a linear model, stated as: 
   P    A  
p
100
   B  
100  p
100
  (6) 
, where µP is the expected maximum of the mixture, based on the maximum 
stimulation of compound A tested alone (µA) and the percent proportion of 
A in the mixture, given as (p), and the maximum stimulation of compound 
B (µB) and the proportion of B (100-p) in the mixture. The model by Beltz 
et al. (2008) was proposed for binary mixtures, as reflected in equation 6, but 
can theoretically be extended to an infinite amount of compounds.    32
 
Knowing the concentration of the maximum secretion level and the curve 
from the level of 0-100% effects, these data can be used to model the non-
monotonic  response  according  to  equation  5  to  yield  the  final  model 
prediction. 
 
For  most  chemicals  there  are  numerous  potential  sites  of  action, 
unfortunately  often  not  known.  CA  can  in  some  cases  overestimate  an 
antagonistic effect when the basic assumptions cannot be met (Goldoni & 
Johansson, 2007) and competition for sites of action may influence the effect 
of the compounds.  
3.4.2  Independent action 
The concept of IA was proposed by Bliss (1939) and assumes that two or 
more compounds of a mixture act in an independent way. Therefore the 
MoA of one chemical has no direct impact on the MoA of another chemical 
in  the  mixture  (Lambert  &  Lipscomb,  2007).  IA  was  first  designed  for 
modulation  of  quantal  responses,  such  as  live  or  dead,  but  has  been 
successfully used for graded responses (Backhaus et al., 2004a):  
  Emix  1  1  E1      1  E2     ...1  En        1  1  En   
i 1
n
    (7) 
Emix is the fraction affected by the mixture and E1, E2…En are the fractions 
affected by the individual chemicals. IA can also be expressed in terms of the 
unaffected fraction, R, which by definition is 1-E: 
  Rmix   R1  R2  ...Rn   Rn
i 1
n
    (8) 
, where Rmix is the response of the mixture given as the unaffected fraction, 
while  R1,  R2...Rn  are  the  responses  of  the  individual  chemicals  in  the 
mixture. In contrast to the standard probabilistic IA model, here we define 
the response to be the relative hormone secretion compared to the control 
set to 100%. 
 
Most chemicals probably have some actions that are not fully independent 
from those of other chemicals. This is one limitation with the IA model, 
since chemicals with overlapping MoA cannot be properly tested (Goldoni 
& Johansson, 2007). 
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4  Results and discussion 
The aim of this thesis was to screen the human adrenocarcinoma cell line 
H295R for effects of single chemicals and mixtures on steroidogenesis. The 
chemicals were tested during basal or stimulated conditions, and mechanisms 
behind observed effects were investigated.  
 
Effects of chemicals on hormone secretion were measured by ELISA. More 
detailed  information  about  mechanisms  behind  the  observed  hormone 
secretion patterns was achieved by using gene expression analysis and ELISA 
based enzyme activity assays. In general, the H295R cell line appears to be a 
promising  tool  to  address  effects  on  steroidogenesis  following  chemical 
exposure. 
4.1  The human H295R cell line as a screening tool for effects of 
chemicals on steroid secretion – paper I 
The chemicals tested in this thesis range from pharmaceuticals and pesticides 
to environmental contaminants. The 30 chemicals tested in paper I were 
selected based on potential effect on steroidogenesis. The chemicals were 
tested  at  the  maximum  concentration  causing  max  10%  unspecific 
cytotoxicity (ICmax10). Thus, the used concentrations are believed to cause 
specific effects on steroid secretion without inducing cytotoxic effects. Cells 
were treated at basal and forskolin- and Ang II-stimulated conditions for 24 
hours, followed by measurements of cortisol and aldosterone secretion levels 
with ELISA.  
 
According to the results, the 30 chemicals in paper I can be divided into 
four categories based on the ICmax10 potency: chemicals with no effect on 
steroid secretion, chemicals with an intermediate inhibitory effect, chemicals   34
with a strong inhibitory effect on hormone secretion and chemicals with 
stimulatory effects on aldosterone secretion.  
4.1.1  Effects of chemicals on the stimulated cortisol and aldosterone pathway 
The cells of the adrenal cortex respond to ACTH or Ang II for activation of 
cortisol  and  aldosterone  secretion,  respectively.  It  was  shown  that  the 
addition  of  forskolin,  to  mimic  ACTH  stimulation,  increased  cortisol 
secretion  in  H295R  cells  2.7-fold.  The  addition  of  Ang  II  increased 
aldosterone secretion from the cells 2.7-fold. In general, the effects of the 
chemicals  were  similar  for  both  basal  and  stimulated  hormone  secretion. 
However,  in  some  cases  the  degree  or  even  direction  of  effects  differed 
between  the  basal  and  induced  hormone  secretion.  Metyrapone,  a 
compound  used  in  diagnosis  and  treatment  of  adrenocortical  disease, 
displayed increased aldosterone secretion at basal conditions but inhibited 
Ang  II-stimulated  aldosterone  secretion.  Similar  effects  were  seen  for 
dibromoacetic acid, a drinking water disinfection by-product, and silymarin, 
a flavonolignan compound with antioxidant properties. In general, analyzing 
and comparing the effects on basal with induced hormone secretion may 
provide additional information suggestive of possible mechanisms. However, 
for rapid screening purposes basal conditions seem adequate to detect most 
of the potential effects of chemicals on cortisol and aldosterone secretion. 
4.1.2  Inhibition and stimulation of hormone secretion 
The results in paper I revealed a number of potent inhibitors of cortisol and 
aldosterone secretion. The most potent steroidogenic inhibitor of the 30 
tested compounds, based on ICmax10, was etomidate, originally used as an 
anaesthetic.  Comparing  the  chemical  effects  on  cortisol  and  aldosterone 
secretion showed that a majority of the observed effects was similar for the 
two pathways. Since both pathways, to a large extent, share and depend on 
the  same  set  of  enzymes  (except  CYP17A1  and  CYP11B2),  this  would 
suggest that the tested chemicals act on one or more of the steroidogenic 
synthesis steps that are common to the two pathways. Some of the other 
potent inhibitors of cortisol and aldosterone secretion were mitotane (o,p’-
DDD), aminoglutethimide, the flavonoids daidzein and 6-hydroxyflavone, 
and  the  imidazoles  prochloraz,  ketoconazole  and  imazalil.  However,  as 
previously indicated for the effects on basal and forskolin/Ang II induced 
steroidogenesis,  some  compounds  also  stimulated  hormone  secretion  in 
H295R cells. Among these were metyrapone, silymarin and dibromoacetic 
acid. The effects of the various compounds used in this thesis shows that the   35 
test system is capable of detecting up-regulation as well as down-regulation 
of steroid secretion.  
4.1.3  Similar chemical structures cause similar effects on steroid secretion 
It was shown that chemicals with structural similarities appear to display the 
same type of effect. The flavonoids daidzein and 6-hydroxyflavone displayed 
marked inhibitory effects on hormone secretion. As mentioned above, the 
imidazoles prochloraz, ketoconazole and imazalil displayed similar inhibitory 
effect on cortisol and aldosterone secretion at the tested concentrations. This 
apparent relation between effect and chemical structure is of interest in a 
screening perspective. 
 
In  summary,  we  showed  that  the  adrenal  steroidogenesis  is  sensitive  to 
chemical disruption, and that the H295R cell line is a promising tool to 
detect these types of effects on cortisol and aldosterone secretion. 
4.2  Mechanistic studies of effects on steroidogenesis – paper II 
In paper II we were interested to use the H295R cell line as a model for 
mechanistic  studies  on  steroidogenesis.  Based  on  the  results  from  the 
screening in paper I we focused on the mechanisms behind the effect of the 
imidazole prochloraz. Prochloraz is a fungicide with anti-androgenic effects, 
including  inhibition  of  testosterone  secretion.  The  effect  on  testosterone 
secretion  was  suggested  to  be  due  to  inhibition  of  CYP17A1  activity 
(Vinggaard et al., 2006). Addressing the effects of this compound on cortisol 
and aldosterone secretion is hence of great interest, since CYP17A1 is also 
required for cortisol secretion. Effects on enzymatic activity as well as gene 
expression  levels  could  explain  the  specific  effects  on  cortisol  and 
aldosterone secretion, and this was investigated in this paper. 
4.2.1  Mechanistic evaluation based on hormone secretion patterns 
The complexity of the steroidogenic pathways, with shared enzymes and 
transporter proteins, complicates the evaluation of the mechanisms of effects 
of  chemicals  on  steroidogenesis.  One  way  to  address  effects  on  the 
steroidogenic pathways is to measure the end products, and in addition the 
intermediate steps of the pathways. This was done in paper II. H295R cells 
were  treated  with  five  concentrations  of  prochloraz,  and  the  levels  of 
cortisol,  aldosterone,  progesterone,  corticosterone  and  17 -OH-
progesterone were determined by ELISA.  
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A  biphasic  dose-response,  with  increased  hormone  secretion  at  lower 
concentrations  followed  by  inhibition  at  higher  concentrations,  was 
observed for aldosterone secretion. Maximum 2.0-fold secretion was noted 
at a concentration of 0.10 µM prochloraz. Aldosterone secretion following 
treatment with prochloraz at 10 µM was inhibited to 23% of control levels. 
In  contrast,  cortisol  secretion  was  dose-dependently  inhibited.  Cortisol 
levels were reduced to 55% of control levels at 0.10 µM prochloraz, the 
same  concentration  where  the  maximum  stimulation  was  reached  for 
aldosterone secretion.  
 
To  investigate  the  mechanisms  behind  observed  effects  further  ELISA 
analyses were performed for selected intermediate steps of the two pathways. 
Biphasic  dose-responses,  with  increased  hormone  secretion  at  lower 
concentrations  followed  by  inhibition  at  higher  concentrations,  were 
observed  for  progesterone,  corticosterone,  and  17 -OH-progesterone 
following  prochloraz  treatment.  Highest  fold-induction  of  hormone 
secretion  was  noted  for  progesterone  with  a  5.3-fold  stimulation  at  a 
prochloraz concentration of 1.0 µM. The biphasic pattern for corticosterone 
was almost identical to the observed effect for aldosterone, with maximum 
secretion of 2.1-fold noted at 0.10 µM prochloraz. Biphasic effect was also 
shown for 17 -OH-progesterone secretion with a maximum of 1.3-fold at 
0.30 µM prochloraz. All results except for the biphasic effect shown for 
17 -OH-progesterone  were  in  favour  of  a  hypothesis  implying  an 
inhibition of CYP17A1. An inhibition of CYP17A1-activity would have 
explained the decrease in cortisol secretion and the increase in aldosterone, 
corticosterone and progesterone secretion, since the steroid substrates would 
be directed down the aldosterone pathway if CYP17A1 was blocked (Fig. 
4).  The  biphasic  effect  on  17 -OH-progesterone  was  unexpected  and 
hence  required  an  adjusted  hypothesis.  We  therefore  speculated  that  the 
observed effects could be caused by an additional inhibition of CYP21A2. A 
subsequent  inhibition  of  CYP21A2-activity  would  explain  the  observed 
decrease in hormone secretion of corticosterone, aldosterone and 17 -OH-
progesterone  at  higher  concentrations  of  prochloraz  treatment.  An 
inhibition  of  CYP21A2  would  also  explain  why  progesterone  secretion 
increased (accumulated) up to a concentration of 1.0 µM prochloraz, since 
progesterone could not be further synthesised.  
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4.2.2  Mechanistic studies based on gene expression 
Chemicals  interfering  with  the  transcription  of  steroidogenic  genes  may 
influence steroid synthesis and secretion. It was, however, demonstrated that 
gene  expression  only  partially  could  explain  the  observed  effects  on 
hormone secretion pattern following prochloraz treatment in paper II. The 
gene expression analysis revealed that prochloraz caused a dose-dependent 
down-regulation  of  all  analysed  steroidogenic  genes,  except  CYP11B2. 
CYP11B2 showed no effect on gene expression levels except for a slight 
down-regulation  at  0.3-1.0  µM  and  a  marked  up-regulation  at  10  µM 
prochloraz.  This  pattern  of  CYP11B2-expression  for  prochloraz  did  not 
explain  the  observed  effect  on  aldosterone  secretion.  The  expression  of 
CYP17A1 was inhibited even at the lowest concentration of prochloraz, 
supporting  the  hypothesis  that  this  enzyme  is  involved  in  the  effects  on 
cortisol and aldosterone secretion observed at low concentrations. Since the 
most  common  mechanism  of  action  in  adrenal  toxicology  involves 
interaction with one or more steroidogenic enzymes (Harvey et al., 2007; 
Rosol et al., 2001; Harvey, 1996) it may not be so surprising that gene 
expression levels cannot fully explain the observed effects on steroidogenesis.  
4.2.3  Mechanistic studies based on enzyme activity assays 
To verify that prochloraz inhibits CYP17A1 and CYP21A2, as suggested by 
the  hormone  secretion  patterns,  we  used  a  combined  CYP21A2-  and 
CYP11B1-activity  assay,  a  CYP11B1-activity  assay,  and  modified  a 
CYP17A1-activity assay to investigate the effects on the implied enzymatic 
steps.  The  activity  of  the  enzymes  was  tested  by  adding  the  preceding 
steroid substrate and measure the level of cortisol and DHEA secretion. The 
results indicated that CYP11B1-activity was not influenced by prochloraz 
treatment. Prochloraz was shown to dose-dependently inhibit the activity of 
CYP17A1  and  CYP21A2.  The  overall  inhibition  or  inhibitory  trend  of 
steroid  secretion  at  10  µM  prochloraz  may  be  ascribed  to  unspecific 
inhibition of imidazoles at higher concentrations (Ayub & Levell, 1989). 
Taken  together,  the  study  performed  in  paper  II  demonstrated  that 
prochloraz  caused  a  dose-dependent  inhibition  of  CYP17A1  and 
CYP21A2-activity. These effects on enzyme activity explained the observed 
hormone secretion patterns following prochloraz treatment. The results also 
showed  that  the  H295R  cell  line  appear  to  be  a  promising  tool  for 
mechanistic studies on steroidogenesis.   38
4.3  Dose-response effects of single chemicals and mixtures on 
steroidogenic pathways – paper III & IV 
Mixtures are of a growing concern and have attracted an increasing interest 
in toxicology research. In paper III and IV the single and mixture effects of 
three imidazoles and three naturally occurring flavonoids, respectively, were 
addressed  on  steroid  secretion.  The  dose-response  of  the  individual 
chemicals was compared with the observed dose-response of the mixture. 
Since  prediction  models  are  of  increasing  interest  in  the  assessment  of 
mixtures, we found it relevant to compare the observed mixture effects on 
steroid secretion in H295R cells with the predicted mixture effects from 
two well recognized prediction models, CA and IA.  
4.3.1  Effects of single chemicals and mixtures of imidazoles on 
steroidogenesis – paper III 
In paper I it was shown that prochloraz, ketoconazole and imazalil were 
potent inhibitors of cortisol and aldosterone secretion. In paper II it was 
shown that prochloraz displayed a monotonic dose-dependent inhibition of 
cortisol secretion, but caused a biphasic aldosterone secretion pattern, with 
low-dose  stimulation  and  high-dose  inhibition.  The  question  emerged 
whether this was a specific effect for prochloraz or if this was a general effect 
for other imidazoles. Further, since mixtures are of increasing interest in 
toxicology the combined effect of prochloraz, ketoconazole and imazalil was 
investigated and compared with the predicted mixture effect according to 
the CA and IA model.  
 
H295R  cells  were  treated  with  nine  different  concentrations  of  the 
individual  imidazoles.  A  ternary  mixture  based  on  a  1:1:1  ratio  of  the 
imidazoles was tested at eight different concentrations. Binary mixtures were 
tested  at  two  concentrations,  where  the  imidazoles  contributed  equally. 
Following treatments, levels of cortisol and aldosterone were determined by 
ELISA. 
Effect of prochloraz, ketoconazole, imazalil, and their mixtures on cortisol and 
aldosterone secretion 
It  was  shown  that  prochloraz,  ketoconazole  and  imazalil,  as  well  as  the 
ternary  imidazole  mixture,  inhibited  cortisol  secretion  in  a  similar 
monotonic  order.  The  inhibition  was  almost  complete  at  an  imidazole 
concentration  of  approximately  10  µM  and  was  evident  even  at  sub-
micromolar concentrations. The EC50 values for cortisol secretion following 
treatment with prochloraz, imazalil and the ternary mixture were identical   39 
(0.13 µM), ketoconazole had a slightly higher EC50 value (0.15 µM). This 
indicated that the three imidazoles act in an additive manner over the tested 
concentration range.  
 
In contrast to the effects on cortisol secretion, prochloraz, ketoconazole and 
the  ternary  mixture  caused  biphasic  effects  on  aldosterone  secretion. 
Maximum secretion, with 2.1-fold stimulation for prochloraz and 1.3-fold 
for ketoconazole, was shown at 0.06 and 0.23 µM, respectively. In contrast 
to  prochloraz  and  ketoconazole,  imazalil  caused  a  monotonic  dose-
dependent  inhibition  of  aldosterone  secretion.  This  indicated  that  the 
biphasic  response  is  not  general  for  all  imidazoles.  The  effect  of 
ketoconazole  and  imazalil  will  require  further  study  to  explain  the 
mechanisms  behind  the  observed  aldosterone  secretion  pattern  for  these 
imidazoles. Most likely, the noted difference in effect for the three single 
imidazoles is due to their different selectivity and potency regarding effects 
on  specific  CYP  enzymes  (Rotstein  et  al.,  1992;  Ayub  &  Levell,  1989; 
Drummond  et  al.,  1988).  The  biphasic  pattern  for  the  ternary  mixture 
displayed a 1.7-fold stimulation of aldosterone secretion at a concentration 
of  0.11  µM.  The  magnitude  of  the  stimulatory  response  was  lower 
compared to prochloraz alone, but larger than the effect of ketoconazole. 
However,  at  concentrations  above  1.0  µM  all  three  imidazoles  and  the 
ternary  mixture  inhibited  aldosterone  secretion,  although  with  lower 
potency than the inhibitory effect on cortisol.  
Predicting effects of the imidazole mixture based on the CA and IA models 
The  CA  and  IA  predictions  excellently,  and  equally  well,  described  the 
observed effects of the imidazole mixture on cortisol secretion. Since IA and 
CA equally well described cortisol secretion following mixture treatment, 
no conclusion could be drawn regarding which model should be preferred 
in this case. 
 
Currently, there is no generally accepted model to predict effects displaying 
non-monotonic dose-responses. Belz et al. (2008) have proposed a modified 
CA model to circumvent this. The modified CA model by Belz et al. (2008) 
was applied to the effects of the imidazoles and was shown to predict the 
stimulatory  effect  of  the  mixture  quite  well.  The  modified  model  is, 
however,  not  mechanistically  founded  since  the  mechanism  behind 
stimulatory responses is not generally understood. Therefore, it remains to 
be  determined  to  what  extent  the  modified  CA  model  is  generally 
applicable for non-monotonic responses.    40
 
The IA prediction model is based on quantal responses and has not been 
used for non-monotonic dose-responses. The modified IA model used in 
this thesis resulted in a marked overestimation of the stimulatory effect and 
an  underestimation  of  the  inhibitory  effect  of  the  imidazoles.  Thus,  the 
modified IA model failed to predict the non-monotonic dose-response.  
Observed and predicted effects of binary imidazole mixtures 
Rather than establishing full dose-response curves for binary mixtures, we 
compared  the  CA  and  IA  predictions  with  data  from  two  imidazole 
concentrations  where  we  observed  big  differences  between  cortisol  and 
aldosterone secretion. As for the ternary mixture, CA and IA predictions of 
cortisol secretion were overlapping and the observed binary effect of the 
mixture generally aligned very well with the predicted curves. The situation 
for  aldosterone  secretion  was  more  complex.  Modified  CA  and  IA 
prediction curves including prochloraz displayed a biphasic pattern, while 
the  predicted  curve  for  the  ketoconazole-imazalil  mixture  was  close  to 
monotonic. The modified CA model predicted the observed effect of the 
binary mixtures well, whereas the modified IA model failed once more in 
describing the biphasic effect on aldosterone secretion. 
Effects of single imidazoles and binary mixtures on gene expression 
Gene expression analysis was performed for the single imidazoles and the 
binary mixture to address possible mechanisms behind the effects. Only a 
modest down-regulation following treatment with the individual imidazoles 
and their binary combination at 0.03 µM were displayed. Most prominent 
were the effects for 3 HSD2 and CYP21A2, which were down-regulated 
to  55%  of  control  levels.  However,  as  previously  described  in  paper  II, 
effects  on  gene  expression  alone  cannot  satisfactorily  explain  the  distinct 
patterns in cortisol and aldosterone secretion following imidazole treatment. 
 
Taken together, the results in paper III indicated that the three imidazoles 
prochloraz,  ketoconazole  and  imazalil  inhibited  cortisol  secretion  in  a 
monotonic, additive and predictive way. The biphasic aldosterone secretion 
pattern was shown to be specific for the tested imidazoles and could not 
easily be predicted by the modified prediction models. The modified CA 
prediction  model  looks  promising,  but  requires  further  refinement  and 
empirical support.  
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4.3.2  Effects of single chemicals and a mixture of flavonoids on 
steroidogenesis – paper IV 
Flavonoids are potent inhibitors of cortisol (Ohno et al., 2002; Mesiano et 
al., 1999) and aldosterone secretion, as indicated in paper I, but also affect 
secretion  of  testosterone  (Taxvig  et  al.,  2010;  Ohno  et  al.,  2003)  and 
oestradiol (Taxvig et al., 2010). Thus, in paper IV we wanted to explore the 
effect  on  cortisol,  aldosterone,  testosterone,  and  oestradiol  secretion  in 
H295R cells following treatment with three naturally occurring flavonoids, 
daidzein,  genistein  and  apigenin.  These  compounds  are  very  similar  in 
chemical structure and the isoflavones daidzein and genistein differs only in 
a hydroxyl group in position 5 (Fig. 7). Difference in chemical structure is 
also seen between the flavones and isoflavones. The flavone apigenin has the 
phenol group in position 2, and the isoflavones have the phenol group in 
position 3. Since these flavonoids are naturally present as mixtures in food 
we  found  it  of  high  interest  to  study  the  effects  of  a  mixture,  and  to 
compare the observed effects of the mixture with predictions from the CA 
and  IA  model.  The  individual  flavonoids  were  tested  at  five  different 
concentrations and the mixture was based on a 1:1:1 ratio of each flavonoid 
tested at six concentrations. Hormone secretion levels from H295R cells 
were measured by ELISA. 
Effect of daidzein, genistein, and apigenin on cortisol, aldosterone, testosterone and 
oestradiol secretion 
All  three  flavonoids  displayed  dose-dependent  inhibition  of  cortisol, 
aldosterone and testosterone secretion, with daidzein and genistein showing 
higher  potency  than  apigenin.  In  contrast,  oestradiol  secretion  was  only 
inhibited by apigenin. The most sensitive targets of the flavonoids were the 
secretion  of  cortisol  and  testosterone,  where  daidzein  and  genistein 
presented  EC50  values  below  1.0  µM.  In  contrast,  apigenin  had  an  EC50 
value  of 2.0 µM for cortisol secretion  and 5.5 µM for the inhibition of 
testosterone secretion. A decrease in cortisol secretion has previously been 
demonstrated in H295R cells following treatment with daidzein (Ohno et 
al., 2002; Mesiano et al., 1999), genistein (Ohno et al., 2002; Mesiano et al., 
1999)  and  apigenin  (Ohno  et  al.,  2002).  These  in  vitro  results  indicate  a 
direct  effect  of  flavonoids  on  steroid  biosynthesis.  The  results  are  in 
agreement  with  in  vivo  data  from  rats  treated  with  genistein,  showing  a 
significantly decreased serum corticosterone concentration and a tendency of 
decreased testosterone levels (Ohno et al., 2003). Decrease in testosterone 
secretion in H295R cells, following daidzein and genistein treatment, has 
been reported by Taxvig et al. (2010).   42
 
In paper IV it was shown that aldosterone secretion was dose-dependently 
inhibited by the three flavonoids. Daidzein had an EC50 value of 1.6 µM on 
aldosterone  secretion,  genistein  had  a  slightly  higher  EC50  of  2.2  µM. 
Apigenin was a less potent inhibitor and displayed an EC50 value of 8.7 µM. 
A  previous  study  in  orchidectomized  rats  treated  with  genistein  has 
indicated  decreased  levels  of  aldosterone  and  corticosterone  in  blood 
(Ajdzanovic et al., 2009). Our in vitro results are in line with the trend in the 
in vivo data presented by Ajdzanovic et al. (2009).  
 
The observed effects on cortisol, aldosterone and testosterone secretion may 
be ascribed to potent effect of daidzein and genisteins as 3 HSD2-inhibitors 
and their effect on CYP21A2-activity (Ohno et al., 2002; Mesiano et al., 
1999).  Flavonoids  with  the  phenolic  ring  in  position  3  in  the  chemical 
backbone  (daidzein  and  genistein,  not  apigenin)  have  been  suggested  as 
3 HSD2-  and/or  17 HSD-inhibitors  (Le  Bail  et  al.,  2000),  which  may 
explain the more potent testosterone inhibition of daidzein and genistein, 
compared to the effect of apigenin.  
 
Taxvig  et  al.  (2010)  reported  increased  oestradiol  secretion  following 
daidzein and genistein treatment of H295R cells, which we did not find. 
This  disagreement  in  observed  effect  may  be  due  to  differences  in 
experimental design. The lack of inhibition of oestradiol for daidzein and 
genistein compared to the inhibition of testosterone secretion, could be due 
to stimulation of CYP19-activity in H295R cells (Sanderson et al., 2004), 
thereby compensating for the inhibition of upstream enzymes. Le Bail et al. 
(2000) suggested that flavonoids with the phenolic ring in position 2 of the 
chemical backbone (i.e. apigenin) were more potent inhibitors of oestradiol 
secretion,  and  Sanderson  et  al.  (2004)  have  reported  apigenin  to  inhibit 
CYP19-activity. These studies are in line with our results, where apigenin 
was shown to be a potent inhibitor of oestradiol secretion with an EC50 of 
6.4 µM.  
Observed and predicted effects of the flavonoid mixture 
The flavonoid mixture inhibited secretion of all steroid hormones, including 
oestradiol, in a dose-dependent way. Cortisol secretion had an EC50 value of 
0.6 µM, aldosterone secretion 3.1 µM, testosterone secretion 0.9 µM, and 
oestradiol secretion 5.5 µM. The CA and IA prediction models described 
the observed effects on cortisol, aldosterone and testosterone secretion well. 
This indicated that the three flavonoids act in an additive way at the tested 
concentrations. Both models, however, failed to predict the observed effect   43 
on oestradiol secretion. In general, the IA and CA prediction models equally 
well described the effects of the flavonoid mixture. 
 
Taken together, the results in paper IV indicated that the three flavonoids 
daidzein,  genistein  and  apigenin  inhibited  steroid  secretion,  with  the 
exception  for  oestradiol  secretion  following  daidzein  and  genistein 
treatment.  The  three  flavonoids  in  general  displayed  additive  effects  on 
steroid secretion. The observed mixture effect on cortisol, aldosterone and 
testosterone secretion was described well by both CA and IA prediction 
models,  while  both  models  underestimated  the  effect  on  oestradiol 
secretion.     44
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5  Concluding remarks 
The focus of this thesis has been effects of chemicals on the human adrenal 
steroidogenesis. A human in vitro model, based on the adrenocarcinoma cell 
line H295R, would more appropriately reflect effects on the human adrenal 
steroidogenesis  than  animal  models.  The  H295R  cell  line  is  already 
undergoing a validation process by the OECD as a screening tool to address 
effects of chemicals on testosterone and oestradiol secretion. 
 
It was concluded that the H295R cell line is a promising tool to address 
effects on human steroidogenesis and production of cortisol and aldosterone, 
in addition to testosterone and oestradiol. Chemicals inhibited as well as 
stimulated hormone secretion, showing that the H295R cell line is able to 
detect both up-regulation as well as down-regulation of steroid secretion. 
Further,  the  H295R  cells  responded  to  a  cAMP-inducer  and  Ang  II  by 
increasing cortisol and aldosterone secretion, respectively. It was shown that 
the cell model could differentiate between specific effects of chemicals on 
basal steroid secretion compared to effects on stimulated steroid secretion.  
 
The  H295R  cells  synthesise  and  secrete  all  steroids  of  the  steroidogenic 
pathway,  which  makes  this  cell  line  a  good  screening  tool  where 
quantitative  as  well  as  qualitative  information  on  several  steroids  can  be 
obtained from one test. One way to further develop the model would be to 
simultaneously determine the level of all steroid hormones and intermediates 
by  new  high-performance  liquid  chromatography/tandem  mass 
spectrometry (LC-MS/MS), excluding the need for steroid specific ELISAs. 
We have just initiated an investigation using this method for analysis.  
 
It  was  concluded  that  imidazoles  displayed  chemical  specific  effects  on 
cortisol and aldosterone secretion, and mechanistic data from the H295R   46
cells facilitated the explanation of these effects. Since the H295R cell line 
proved to be a promising tool for mechanistic studies, further research is 
encouraged to explore the mechanisms behind the effects of ketoconazole 
and imazalil. 
 
The  three  natural  flavonoids  tested  in  this  thesis  inhibited  cortisol, 
aldosterone, testosterone and oestradiol secretion in concentrations similar to 
the  levels  detected  in  human  plasma.  The  effect  of  flavonoids  on 
steroidogenesis  indicates  that  natural  compounds  may  be  more  potent 
disruptors  of  the  endocrine  system,  than  synthetic  compounds.  It  was 
concluded that the isoflavones (daidzein and genistein) were more potent 
inhibitors  of  steroidogenesis  than  the  flavone  (apigenin),  except  for 
oestradiol secretion where the opposite was shown. This difference in effect 
between the isoflavones and the flavone may be due to chemical specific 
effects on enzyme activity. 
 
In  this  thesis  effects  of  chemical  mixtures  on  steroidogenesis  have  been 
addressed  by  treating  the  H295R  cells  with  mixtures  of  imidazoles  and 
flavonoids. Prediction models such as CA and IA was shown to be valuable 
tools in the assessment of mixture effects. However, the imidazole mixture 
highlighted the problem with predicting effects of biphasic dose-response 
patterns. A modified CA model could partially describe the biphasic effect 
for the imidazole mixture on aldosterone secretion. This modified model 
requires  further  assessment,  in  order  to  evaluate  its  potential  to  predict 
biphasic effects.  
 
Further research into effects of mixtures is encouraged, since mixtures are 
the most likely way of exposure to humans and animals. It would be of 
interest  to  investigate  the  mixture  effect  of  compounds  with  established 
mechanisms of action, e.g. chemicals with dissimilar MoA. 
 
An in vitro model for effects on adrenal steroidogenesis does not exclude the 
need for in vivo studies. In vitro models can provide detailed information 
about  the  direct  effects  of  a  chemical,  or  mixture,  on  the  adrenal 
steroidogenesis.  The  adrenal  steroid  secretion  is  under  influence  of  the 
HPA-axis and/or RAS, which is not easily assessed with an adrenal in vitro 
model. We have tried to mimic stress and salt regulated activation of the 
adrenal steroidogenesis by stimulating the cells with a cAMP inducer and 
Ang  II.  Still,  animal  models  are  required  to  study  adaptive  responses  to 
effects on steroidogenesis in vivo. It could be argued that down-regulation of   47 
steroidogenesis may be compensated for by activation of the HPA-axis and 
RAS.  However,  it  may  be  harder  for  the  endocrine  system  to  adapt  to 
stimulation of steroidogenesis by chemicals.  
 
The  liver  is  the  main  organ  responsible  for  metabolism  of  dietary 
compounds  and  chemicals.  Combining  the  H295R  model  with  a 
metabolising  system  would  make  it  possible  to  detect  effects  from 
metabolites as well, providing further insights to the possible effects of single 
chemicals and mixtures on the steroidogenic pathway. 
 
It is recommended to consider the H295R cell line as a screening tool for 
effects on cortisol and aldosterone secretion, in addition to the effects on 
testosterone and oestradiol secretion that the OECD is evaluating this model 
for.  In  this  thesis  we  have  shown that  the  H295R  cell  line  also  can  be 
applied for investigation of mechanistic studies.  
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Populärvetenskaplig sammanfattning 
Binjuren  är  ett  endokrint  organ  som  producerar  och  utsöndrar 
steroidhormoner såsom kortisol och aldosteron. I denna avhandling har vi 
undersökt olika kemikaliers effekt på steroidproduktionen i binjurebarken.  
 
Hormonstörande ämnen är ett samlingsnamn för kemikalier, enskilda eller 
blandningar, som påverkar funktionen av ett hormonsystem. Detta kan leda 
till  effekter  på  vår  hälsa,  påverka  fortplantningsförmågan,  samt  störa  den 
tidiga  utvecklingen.  Hormonstörande  ämnen  har  länge  ansetts  utöva  sin 
effekt genom att binda till receptorer, som normalt känner igen signaler från 
olika hormoner i kroppen. Men, utöver dessa receptorförmedlade effekter 
har  man  börjat  uppmärksamma  direkta  effekter  av  dessa  substanser  på 
hormonproduktionen. Dessa direkta effekter kan också få till följd att vår 
hälsa  påverkas,  då  hormonnivåerna  i  kroppen  kan  förändras  på  grund  av 
kemikalierna. Hormonstörande ämnen återfinns bland ett flertal grupper av 
kemikalier och vi utsätts dagligen för dessa genom till exempel läkemedel, 
naturligt  förekommande  ämnen  i  mat,  samt  bekämpningsmedel  eller 
miljöföroreningar. Många av dessa ämnen utsätts vi för samtidigt, som en 
blandning av olika kemiska föreningar. 
 
Binjurebarken  producerar  och  utsöndrar  huvudsakligen  tre  typer  av 
steroidhormoner,  nämligen  kortisol,  som  reglerar  metabolismen  av 
kolhydrater och protein, stress samt immunförsvar; aldosteron, som reglerar 
saltbalansen  och  därmed  indirekt  även  blodtrycket;  samt  så  kallade  svaga 
androgener/könshormon. Kemikalier som påverkar produktionen av dessa 
hormon kan störa grundläggande funktioner i kroppen och orsaka sjukdom. 
Det  är  viktigt  att  det  finns  bra  verktyg,  så  som  olika  cellmodeller  eller 
djurförsök, för att upptäcka dessa typer av effekter. I denna avhandling har   50
en  human  binjurecellmodell,  H295R,  använts  för  att  studera  de 
hormonstörande ämnenas effekter på produktionen av steroidhormoner.  
 
Flera kemikalier med misstänkta effekter på steroidproduktionen studerades 
genom att utsätta cellerna för dessa ämnen i cellodlingsmediumet. Mängden 
utsöndrad  hormon  efter  kemikalieexponeringen  bestämdes  sedan  i 
mediumet. Huvudsakligen har effekter på produktionen och utsöndringen 
av kortisol och aldosteron studerats, men även effekter på produktionen och 
utsöndringen  av  könshormonerna  testosteron  och  östradiol,  samt  vissa 
mellansteg  i  steroidproduktionen.  Normalt  producerar  inte  binjuren 
könshormon, men cellinjen som använts i denna avhandling kan producera 
och utsöndra alla typer av steroidhormoner. Bland det trettiotal kemikalier 
som  studerats  uppvisades  tydliga  skillnader  i  effekt  på  utsöndringen  av 
kortisol  och  aldosteron.  Vanligast  var  att  kemikalierna  hämmade 
utsöndringen  av  kortisol  och  aldosteron,  medan  ett  fåtal  av  kemikalierna 
ökade utsöndringen.  
 
En kemikalie som studerats närmare är prokloraz. Denna kemikalie används 
som svampbekämpningsmedel inom växt- och livsmedelsproduktionen. När 
cellerna  utsattes  för  prokloraz  hämmades  kortisolutsöndringen. 
Utsöndringen  av  aldosteron  var  stimulerad  vid  låga  koncentrationer  av 
prokloraz,  men  hämmades  vid  höga  koncentrationer.  En  hämning  av 
aktiviteten av enzymerna CYP17A1 och CYP21A2 kunde förklara varför 
utsöndringen av kortisol gick ned medan utsöndringen av aldosteron gick 
upp vid låga koncentrationer av prokloraz.  
 
Eftersom vi utsätts för många potentiella hormonstörande ämnen samtidigt 
studerade vi även effekter av blandningar och inte bara enskilda kemikalier. 
Två grupper av kemikalier valdes ut för blandningsstudier, imidazoler och 
flavonoider. Till imidazolerna räknas prokloraz, ketokonazol och imazalil, 
vilka alla har en svampdödande effekt och används inom jordbruket eller 
inom medicin. Flavonoider är naturligt förekommande ämnen som vi får i 
oss via föda. Tre flavonoider har studerats närmare, daidzein, genistein (finns 
i  sojabönor)  och  apigenin  (finns  i  persilja  och  selleri).  På  grund  av 
svårigheten  att  testa  alla  blandningar  vi  utsätts  för  har  det  tagits  fram 
matematiska modeller för att beräkna en blandningseffekt utifrån kunskap 
om  de  enskilda  kemikaliernas  effekter.  Vi  har  jämfört  våra  resultat  från 
kemikalieblandningarna med resultat från matematiska modeller. Generellt 
sett  visade  det  sig  att  modellerna  fungerar  bra  för  både  imidazol-  och 
flavonoidblandningarna, dock förekom vissa avvikelser. Mest problematiskt   51 
blev det att beräkna effekten av imidazolblandningen på produktionen av 
aldosteron, där det krävdes modifierade matematiska modeller.  
 
Sammanfattningsvis visade vi att steroidproduktionen är känslig för påverkan 
av kemikalier och att cellinjen H295R verkar vara en lovande modell för att 
studera  hormonstörande  ämnens  effekt  på  binjurebarkens  hormon-
produktion. De matematiska modeller som använts i denna avhandling är 
värdefulla redskap i utvärderingen av kemikalieblandningar. 
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